C A Marzetta

Large buoyant LDL-like particles in hepatic lipase deficiency.

Johan Auwerx, C A Marzetta, John E. Hokanson et al. · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · 142 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +16

Pharmacologic consequences of cholesterol absorption inhibition: alteration in cholesterol metabolism and reduction in plasma cholesterol concentration induced by the synthetic saponin beta-tigogenin cellobioside (CP-88818; tiqueside).

H. James Harwood, M.R. Malinow, C A Marzetta · Journal of Lipid Research · 1993 · 139 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

A species comparison of low density lipoprotein heterogeneity in nonhuman primates fed atherogenic diets.

C A Marzetta, L L Rudel · Journal of Lipid Research · 1988 · 51 citations · Full text

Life Sciences, Biochemistry, Animal Nutrition +15

Metabolic behavior of hepatic VLDL and plasma LDL apoB-100 in African green monkeys.

C A Marzetta, F L Johnson, Loren A. Zech et al. · Journal of Lipid Research · 1989 · 41 citations · Full text

Life Sciences, Biochemistry, Hepatic Pharmacokinetics +16

Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys

C A Marzetta, Yvette E. Savoy, Ann Freeman et al. · Journal of Lipid Research · 1994 · 40 citations · Full text

Medicine, Biochemistry, Pharmacology +17